J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Former Google Exec Steps Down as GRAIL CEO August 2, 2017 Bay Area's AirXpanders Bags $34 Million In Private Placement January 29, 2017 Afraxis, Inc. Announces New Imagedirect (SM) Analysis Service March 9, 2017
